Esperion Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
ESPR on Nasdaq
Industry
Pharmaceutical Preparations
Location
3891 Ranchero Drive, Suite 150, Ann Arbor, MI

Insiders trading volume in the past year

Esperion Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Biotech Target N V 10%+ Owner $5.58M May 24, 2021
Sheldon L. Koenig President and CEO, Director $1.82M -$56.8K -3.02% Dec 17, 2024
Joanne M. Foody Chief Medical Officer $709K -$11.8K -1.64% Jul 17, 2024
Benjamin Halladay Chief Financial Officer $583K -$7.87K -1.33% Dec 17, 2024
Eric Warren Chief Commercial Officer $389K -$19.2K -4.69% Dec 17, 2024
J. Martin Carroll Director $161K May 23, 2024
Alan Fuhrman Director $133K May 23, 2024
Gotto Antonio M Jr Md D Phil Director $128K May 23, 2024
Jay Shepard Director $128K May 23, 2024
Benjamin Looker General Counsel $104K Mar 14, 2024
Richard Bartram Chief Financial Officer $103K Mar 14, 2022
Stephen Rocamboli Director $90K May 23, 2024
H. Fischer Seth Director $69.9K May 23, 2024
Daniel Janney Director $59.8K May 27, 2021
Nicole Vitullo Director $46K May 23, 2024
Tracy M. Woody Director $41.8K May 23, 2024
Mark E. Mcgovern Director $35.4K May 27, 2021
Jeffrey Berkowitz Director May 26, 2022

Recent Insider Transactions by Companies or Individuals for Esperion Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.